Literature DB >> 35108018

Antibodies with Weakly Basic Isoelectric Points Minimize Trade-offs between Formulation and Physiological Colloidal Properties.

Priyanka Gupta1,2, Emily K Makowski3, Sandeep Kumar2, Yulei Zhang4, Justin M Scheer2,5, Peter M Tessier1,3,4,6.   

Abstract

The widespread interest in antibody therapeutics has led to much focus on identifying antibody candidates with favorable developability properties. In particular, there is broad interest in identifying antibody candidates with highly repulsive self-interactions in standard formulations (e.g., low ionic strength buffers at pH 5-6) for high solubility and low viscosity. Likewise, there is also broad interest in identifying antibody candidates with low levels of non-specific interactions in physiological solution conditions (PBS, pH 7.4) to promote favorable pharmacokinetic properties. To what extent antibodies that possess both highly repulsive self-interactions in standard formulations and weak non-specific interactions in physiological solution conditions can be systematically identified remains unclear and is a potential impediment to successful therapeutic drug development. Here, we evaluate these two properties for 42 IgG1 variants based on the variable fragments (Fvs) from four clinical-stage antibodies and complementarity-determining regions from 10 clinical-stage antibodies. Interestingly, we find that antibodies with the strongest repulsive self-interactions in a standard formulation (pH 6 and 10 mM histidine) display the strongest non-specific interactions in physiological solution conditions. Conversely, antibodies with the weakest non-specific interactions under physiological conditions display the least repulsive self-interactions in standard formulations. This behavior can be largely explained by the antibody isoelectric point, as highly basic antibodies that are highly positively charged under standard formulation conditions (pH 5-6) promote repulsive self-interactions that mediate high colloidal stability but also mediate strong non-specific interactions with negatively charged biomolecules at physiological pH and vice versa for antibodies with negatively charged Fv regions. Therefore, IgG1s with weakly basic isoelectric points between 8 and 8.5 and Fv isoelectric points between 7.5 and 9 typically display the best combinations of strong repulsive self-interactions and weak non-specific interactions. We expect that these findings will improve the identification and engineering of antibody candidates with drug-like biophysical properties.

Entities:  

Keywords:  Fv, charge; IgG; colloidal stability; developability; isoelectric point; non-specific; non-specific interaction; off-target binding; pI; polyreactivity; self-association; self-interaction; specificity

Mesh:

Substances:

Year:  2022        PMID: 35108018      PMCID: PMC9350878          DOI: 10.1021/acs.molpharmaceut.1c00373

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   5.364


  66 in total

1.  Viscosity behavior of high-concentration monoclonal antibody solutions: correlation with interaction parameter and electroviscous effects.

Authors:  Sandeep Yadav; Steven J Shire; Devendra S Kalonia
Journal:  J Pharm Sci       Date:  2011-11-23       Impact factor: 3.534

2.  The functional capacity of the natural amino acids for molecular recognition.

Authors:  Sara Birtalan; Robert D Fisher; Sachdev S Sidhu
Journal:  Mol Biosyst       Date:  2010-04-09

Review 3.  Potent antibody therapeutics by design.

Authors:  Paul J Carter
Journal:  Nat Rev Immunol       Date:  2006-05       Impact factor: 53.106

4.  Reversible self-association of a concentrated monoclonal antibody solution mediated by Fab-Fab interaction that impacts solution viscosity.

Authors:  Sonoko Kanai; Jun Liu; Thomas W Patapoff; Steven J Shire
Journal:  J Pharm Sci       Date:  2008-10       Impact factor: 3.534

Review 5.  A review of Formulations of Commercially Available Antibodies.

Authors:  Robert G Strickley; William J Lambert
Journal:  J Pharm Sci       Date:  2021-03-28       Impact factor: 3.534

6.  Specific interactions in high concentration antibody solutions resulting in high viscosity.

Authors:  Sandeep Yadav; Jun Liu; Steven J Shire; Devendra S Kalonia
Journal:  J Pharm Sci       Date:  2010-03       Impact factor: 3.534

7.  Rational design of viscosity reducing mutants of a monoclonal antibody: hydrophobic versus electrostatic inter-molecular interactions.

Authors:  Pilarin Nichols; Li Li; Sandeep Kumar; Patrick M Buck; Satish K Singh; Sumit Goswami; Bryan Balthazor; Tami R Conley; David Sek; Martin J Allen
Journal:  MAbs       Date:  2015       Impact factor: 5.857

Review 8.  Monoclonal antibody therapeutics: history and future.

Authors:  Nicholas A P S Buss; Simon J Henderson; Mary McFarlane; Jacintha M Shenton; Lolke de Haan
Journal:  Curr Opin Pharmacol       Date:  2012-08-21       Impact factor: 5.547

9.  Concentration dependent viscosity of monoclonal antibody solutions: explaining experimental behavior in terms of molecular properties.

Authors:  Li Li; Sandeep Kumar; Patrick M Buck; Christopher Burns; Janelle Lavoie; Satish K Singh; Nicholas W Warne; Pilarin Nichols; Nicholas Luksha; Davin Boardman
Journal:  Pharm Res       Date:  2014-06-07       Impact factor: 4.200

10.  Looking for therapeutic antibodies in next-generation sequencing repositories.

Authors:  Konrad Krawczyk; Matthew I J Raybould; Aleksandr Kovaltsuk; Charlotte M Deane
Journal:  MAbs       Date:  2019-07-17       Impact factor: 5.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.